Categories Articles Merck will ask regulators to authorize the first antiviral pill designed to treat COVID-19, after a trial found it halved the risk of hospitalization or death Post author By crystalg Post date October 1, 2021 Business Insider Business Insider Tags After, Antiviral, authorize, COVID19, Death, Designed, First, found, halved, Hospitalization, Merck, Pill, regulators, risk, treat, Trial ← 3 Defensive Dividend Stocks to Buy Now → Study reveals why night shift workers face much higher risk of cancer